January 02, 2026 a 09:00 pm
ZTS: Analysts Ratings - Zoetis Inc.
Zoetis Inc., a leader in animal health pharmaceuticals, has experienced varied analyst sentiment over recent months. Despite a generally robust business model and consistent performance, the ratings reveal nuances that investors should consider. Recent months suggest a trend towards caution with an uptick in 'Hold' recommendations despite the strong buy base.
Historical Stock Grades
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 5 | |
| Buy | 7 | |
| Hold | 8 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The past few months indicate a cautious approach among analysts, with a steady presence of 'Hold' recommendations signaling risk awareness or market uncertainty.
- Strong Buy ratings have remained stable, showing confidence in Zoetis's long-term potential.
- A consistent level of Buy recommendations suggests maintained optimism despite market variables.
- Recent increases in Hold ratings may indicate emerging caution amid market conditions.
Percentage Trends
A shift towards Hold recommendations sheds light on tempered enthusiasm. Analysts display restraint amid external market dynamics or company-specific factors.
- From December 2025 to January 2026, Hold ratings increased from 40% to 47%.
- Stable Buy and Strong Buy percentages highlight balanced confidence.
- The lack of Sell ratings emphasizes a fundamentally sound company perception.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-12-03 | Buy | Buy | BTIG |
| 2025-11-18 | Hold | Hold | Stifel |
| 2025-11-12 | Buy | Buy | BTIG |
| 2025-11-10 | Overweight | Overweight | Morgan Stanley |
| 2025-11-05 | Neutral | Neutral | UBS |
Analyst Recommendations with Change of Opinion
A few firms have altered their perspective, demonstrating possible shifts in Zoetis's market positioning or broader economic factors.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-17 | Market Perform | Outperform | Leerink Partners |
| 2025-06-18 | Hold | Buy | Stifel |
| 2021-07-16 | Market Perform | Outperform | Raymond James |
| 2021-07-15 | Market Perform | Outperform | Raymond James |
| 2021-03-08 | Buy | Neutral | B of A Securities |
Interpretation
The current analyst sentiment suggests a consistent belief in Zoetis's leadership in animal health, with stable recommendations. However, the rise in Hold ratings amid stable Strong Buys suggests some uncertainty. A stable future outlook is perceived, albeit with potential headwinds that the increase in Hold recommendations may reflect.
Conclusion
Zoetis Inc. remains a strong player in the animal health arena, with consistent analyst support reflected in long-held Buy and Strong Buy ratings. While recent trends depict increased cautiousness through rising Hold ratings, the absence of any Sell indicates confidence in the company's resilience. The stock's future may hinge on broader market conditions, but the company's fundamental strengths provide a buffer against volatility.